{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:46:44Z","timestamp":1794026804646,"version":"4.8.0"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"PolyBio Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Immunol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1038\/s41590-023-01601-2","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T04:14:00Z","timestamp":1693887240000},"page":"1616-1627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":293,"title":["SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9495-8572","authenticated-orcid":false,"given":"Amy D.","family":"Proal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"VanElzakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1297-6337","authenticated-orcid":false,"given":"Brittany P.","family":"Boribong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0633-1719","authenticated-orcid":false,"given":"Marcus","family":"Buggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3956-6610","authenticated-orcid":false,"given":"Sara","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1675-1728","authenticated-orcid":false,"given":"Daniel S.","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6102-256X","authenticated-orcid":false,"given":"Helen E.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0896-6542","authenticated-orcid":false,"given":"Christopher L.","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Eimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Wesley","family":"Ely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4906-7698","authenticated-orcid":false,"given":"Marcelo","family":"Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda N.","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane E.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Henrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7824-9856","authenticated-orcid":false,"given":"Akiko","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Izquierdo-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Locci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9781-2969","authenticated-orcid":false,"given":"Saurabh","family":"Mehandru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0180-2748","authenticated-orcid":false,"given":"Mark M.","family":"Painter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Peluso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etheresia","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9416-2737","authenticated-orcid":false,"given":"David A.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Putrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1355-892X","authenticated-orcid":false,"given":"Richard H.","family":"Scheuermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene S.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7032-1454","authenticated-orcid":false,"given":"Rudolph E.","family":"Tanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"VanBrocklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1711-8227","authenticated-orcid":false,"given":"Lael M.","family":"Yonker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0477-1956","authenticated-orcid":false,"given":"E. John","family":"Wherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"1601_CR1","doi-asserted-by":"publisher","unstructured":"Proal, A. D. & VanElzakker, M. B. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. https:\/\/doi.org\/10.3389\/FMICB.2021.698169 (2021).","DOI":"10.3389\/FMICB.2021.698169"},{"key":"1601_CR2","unstructured":"National Center for Health Statistics. US Census Bureau, Household Pulse Survey, 2022\u20132023. Long COVID (2023)."},{"key":"1601_CR3","unstructured":"Cutler, D. M. The economic cost of long COVID: an update (2023). White Paper. https:\/\/scholar.harvard.edu\/files\/cutler\/files\/long_covid_update_7-22.pdf (2023)."},{"key":"1601_CR4","doi-asserted-by":"publisher","unstructured":"Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. https:\/\/doi.org\/10.1038\/S41579-022-00846-2 (2023).","DOI":"10.1038\/S41579-022-00846-2"},{"key":"1601_CR5","doi-asserted-by":"publisher","unstructured":"Davis, H. E. et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine https:\/\/doi.org\/10.1016\/J.ECLINM.2021.101019 (2021).","DOI":"10.1016\/J.ECLINM.2021.101019"},{"key":"1601_CR6","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/eurheartj\/ehab914","volume":"43","author":"EL Petersen","year":"2022","unstructured":"Petersen, E. L. et al. Multi-organ assessment in mainly non-hospitalized individuals after SARS-CoV-2 infection: the Hamburg City Health Study COVID programme. Eur. Heart J. 43, 1124\u20131137 (2022).","journal-title":"Eur. Heart J."},{"key":"1601_CR7","doi-asserted-by":"publisher","unstructured":"Peluso, M. J. et al. Persistence, magnitude, and patterns of postacute symptoms and quality of life following onset of SARS-CoV-2 infection: cohort description and approaches for measurement. Open Forum Infect. Dis. https:\/\/doi.org\/10.1093\/OFID\/OFAB640 (2022).","DOI":"10.1093\/OFID\/OFAB640"},{"key":"1601_CR8","doi-asserted-by":"publisher","unstructured":"Lopez-Leon, S. et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci. Rep. https:\/\/doi.org\/10.1038\/S41598-022-13495-5 (2022).","DOI":"10.1038\/S41598-022-13495-5"},{"key":"1601_CR9","doi-asserted-by":"crossref","first-page":"E2223253","DOI":"10.1001\/jamanetworkopen.2022.23253","volume":"5","author":"AL Funk","year":"2022","unstructured":"Funk, A. L. et al. Post\u2013COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMA Netw. Open. 5, E2223253 (2022).","journal-title":"JAMA Netw. Open."},{"key":"1601_CR10","unstructured":"Centers for Disease Control and Prevention. Health department-reported cases of multisystem inflammatory syndrome in children (MIS-C) in the United States. https:\/\/www.cdc.gov\/mis\/index.html (2023)."},{"key":"1601_CR11","doi-asserted-by":"publisher","unstructured":"Keita, A. K. et al. A 40-month follow-up of Ebola virus disease survivors in Guinea (Postebogui) reveals long-term detection of Ebola viral ribonucleic acid in semen and breast milk. Open Forum Infect. Dis. https:\/\/doi.org\/10.1093\/ofid\/ofz482 (2019).","DOI":"10.1093\/ofid\/ofz482"},{"key":"1601_CR12","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1056\/NEJMoa1500306","volume":"372","author":"JB Varkey","year":"2015","unstructured":"Varkey, J. B. et al. Persistence of Ebola virus in ocular fluid during convalescence. N. Engl. J. Med. 372, 2423\u20132427 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1601_CR13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/infdis\/jiw078","volume":"214","author":"MS Sow","year":"2016","unstructured":"Sow, M. S. et al. New evidence of long-lasting persistence of Ebola virus genetic material in semen of survivors. J. Infect. Dis. 214, 1475\u20131476 (2016).","journal-title":"J. Infect. Dis."},{"key":"1601_CR14","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJMoa1613108","volume":"379","author":"G Paz-Bailey","year":"2018","unstructured":"Paz-Bailey, G. et al. Persistence of Zika virus in body fluids\u2014final report. N. Engl. J. Med. 379, 1234\u20131243 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1601_CR15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jcp.2007.050054","volume":"61","author":"JKS Chia","year":"2008","unstructured":"Chia, J. K. S. & Chia, A. Y. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J. Clin. Pathol. 61, 43\u201348 (2008).","journal-title":"J. Clin. Pathol."},{"key":"1601_CR16","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1161\/CIRCULATIONAHA.105.548156","volume":"112","author":"U K\u00fchl","year":"2005","unstructured":"K\u00fchl, U. et al. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112, 1965\u20131970 (2005).","journal-title":"Circulation"},{"key":"1601_CR17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1086\/318533","volume":"183","author":"SR Permar","year":"2001","unstructured":"Permar, S. R. et al. Prolonged measles virus shedding in human immunodeficiency virus-infected children, detected by reverse transcriptase-polymerase chain reaction. J. Infect. Dis. 183, 532\u2013538 (2001).","journal-title":"J. Infect. Dis."},{"key":"1601_CR18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jcv.2007.05.006","volume":"39","author":"MA Riddell","year":"2007","unstructured":"Riddell, M. A., Moss, W. J., Hauer, D., Monze, M. & Griffin, D. E. Slow clearance of measles virus RNA after acute infection. J. Clin. Virol. 39, 312\u2013317 (2007).","journal-title":"J. Clin. Virol."},{"key":"1601_CR19","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1473-3099(18)30417-1","volume":"18","author":"EK Dokubo","year":"2018","unstructured":"Dokubo, E. K. et al. Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report. Lancet Infect. Dis. 18, 1015\u20131024 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"1601_CR20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3201\/eid2204.151302","volume":"22","author":"JT Scott","year":"2016","unstructured":"Scott, J. T. et al. Post-Ebola syndrome, Sierra Leone. Emerg. Infect. Dis. 22, 641\u2013646 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"1601_CR21","doi-asserted-by":"crossref","first-page":"S287","DOI":"10.1093\/infdis\/jiy280","volume":"218","author":"L Subissi","year":"2018","unstructured":"Subissi, L. et al. Ebola virus transmission caused by persistently infected survivors of the 2014-2016 outbreak in West Africa. J. Infect. Dis. 218, S287\u2013S291 (2018).","journal-title":"J. Infect. Dis."},{"key":"1601_CR22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-021-03901-9","volume":"597","author":"AK Keita","year":"2021","unstructured":"Keita, A. K. et al. Resurgence of Ebola virus in 2021 in Guinea suggests a new paradigm for outbreaks. Nature 597, 539\u2013543 (2021).","journal-title":"Nature"},{"key":"1601_CR23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/cid\/ciw692","volume":"64","author":"K Russell","year":"2017","unstructured":"Russell, K. et al. Male-to-Female sexual transmission of Zika virus\u2014United States, January\u2013April 2016. Clin. Infect. Dis. 64, 211\u2013213 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"1601_CR24","doi-asserted-by":"publisher","unstructured":"Peluso, M. J. et al. Multimodal molecular imaging reveals tissue-based T cell activation and viral RNA persistence for up to 2 years following COVID-19. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2023.07.27.23293177 (2023).","DOI":"10.1101\/2023.07.27.23293177"},{"key":"1601_CR25","doi-asserted-by":"publisher","unstructured":"Yao, Q. et al. Long-term dysfunction of taste papillae in SARS-CoV-2. NEJM Evidence. https:\/\/doi.org\/10.1056\/EVIDoa2300046 (2023).","DOI":"10.1056\/EVIDoa2300046"},{"key":"1601_CR26","doi-asserted-by":"publisher","unstructured":"Rendeiro, A. F. et al. Persistent alveolar type 2 dysfunction and lung structural derangement in post-acute COVID-19. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2022.11.28.22282811 (2022).","DOI":"10.1101\/2022.11.28.22282811"},{"key":"1601_CR27","doi-asserted-by":"publisher","unstructured":"de Melo, G. D. et al. COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/SCITRANSLMED.ABF8396 (2021).","DOI":"10.1126\/SCITRANSLMED.ABF8396"},{"key":"1601_CR28","doi-asserted-by":"publisher","unstructured":"Cheung, C. C. L. et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut https:\/\/doi.org\/10.1136\/gutjnl-2021-324280 (2021).","DOI":"10.1136\/gutjnl-2021-324280"},{"key":"1601_CR29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11695-022-06338-9","volume":"33","author":"M Hany","year":"2022","unstructured":"Hany, M. et al. Lingering SARS-CoV-2 in gastric and gallbladder tissues of patients with previous COVID-19 infection undergoing bariatric surgery. Obes. Surg. 33, 139\u2013148 (2022).","journal-title":"Obes. Surg."},{"key":"1601_CR30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bjorl.2022.10.016","volume":"88","author":"CS Miura","year":"2022","unstructured":"Miura, C. S. et al. Asymptomatic SARS-COV-2 infection in children\u2019s tonsils. Braz. J. Otorhinolaryngol. 88, 9 (2022).","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"1601_CR31","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","volume":"612","author":"SR Stein","year":"2022","unstructured":"Stein, S. R. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 612, 758\u2013763 (2022).","journal-title":"Nature"},{"key":"1601_CR32","doi-asserted-by":"publisher","unstructured":"Roden, A. C. et al. Late complications of COVID-19: a morphologic, imaging, and droplet digital polymerase chain reaction study of lung tissue. Arch. Pathol. Lab. Med. https:\/\/doi.org\/10.5858\/arpa.2021-0519-sa (2022).","DOI":"10.5858\/arpa.2021-0519-sa"},{"key":"1601_CR33","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","volume":"591","author":"C Gaebler","year":"2021","unstructured":"Gaebler, C. et al. Evolution of antibody immunity to SARS-CoV-2. Nature 591, 639\u2013644 (2021).","journal-title":"Nature"},{"key":"1601_CR34","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.cell.2017.04.008","volume":"169","author":"M Aid","year":"2017","unstructured":"Aid, M. et al. Zika virus persistence in the central nervous system and lymph nodes of rhesus monkeys. Cell 169, 610\u2013620 (2017).","journal-title":"Cell"},{"key":"1601_CR35","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJMoa1711038","volume":"378","author":"PS Mead","year":"2018","unstructured":"Mead, P. S. et al. Zika virus shedding in semen of symptomatic infected men. N. Engl. J. Med. 378, 1377\u20131385 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1601_CR36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.chom.2018.08.003","volume":"24","author":"KM Coffin","year":"2018","unstructured":"Coffin, K. M. et al. Persistent Marburg virus infection in the testes of nonhuman primate survivors. Cell Host Microbe 24, 405\u2013416 (2018).","journal-title":"Cell Host Microbe"},{"key":"1601_CR37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41590-022-01367-z","volume":"24","author":"Q Xu","year":"2022","unstructured":"Xu, Q. et al. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children. Nat. Immunol. 24, 186\u2013199 (2022).","journal-title":"Nat. Immunol."},{"key":"1601_CR38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1053\/j.gastro.2022.04.037","volume":"163","author":"A Zollner","year":"2022","unstructured":"Zollner, A. et al. Postacute COVID-19 is characterized by gut viral antigen persistence in inflammatory bowel diseases. Gastroenterology 163, 495\u2013506 (2022).","journal-title":"Gastroenterology"},{"key":"1601_CR39","doi-asserted-by":"crossref","first-page":"939989","DOI":"10.3389\/fimmu.2022.939989","volume":"13","author":"D Goh","year":"2022","unstructured":"Goh, D. et al. Case report: persistence of residual antigen and RNA of the SARS-CoV-2 virus in tissues of two patients with long COVID. Front Immunol. 13, 939989 (2022).","journal-title":"Front Immunol."},{"key":"1601_CR40","doi-asserted-by":"publisher","unstructured":"Schulthei\u00df, C. et al. Liquid biomarkers of macrophage dysregulation and circulating spike protein 1 illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19. J. Med. Virol. https:\/\/doi.org\/10.1002\/jmv.28364 (2023).","DOI":"10.1002\/jmv.28364"},{"key":"1601_CR41","doi-asserted-by":"publisher","unstructured":"Swank, Z. et al. Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/CID\/CIAC722 (2022).","DOI":"10.1093\/CID\/CIAC722"},{"key":"1601_CR42","unstructured":"Peluso, M. et al. Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection. Poster presentation. https:\/\/www.croiconference.org\/abstract\/plasma-based-antigen-persistence-in-the-post-acute-phase-of-sars-cov-2-infection\/ (2023)."},{"key":"1601_CR43","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/cid\/ciab465","volume":"74","author":"AF Ogata","year":"2022","unstructured":"Ogata, A. F. et al. Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients. Clin. Infect. Dis. 74, 715\u2013718 (2022).","journal-title":"Clin. Infect. Dis."},{"key":"1601_CR44","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ana.26350","volume":"91","author":"MJ Peluso","year":"2022","unstructured":"Peluso, M. J. et al. SARS-CoV-2 and mitochondrial proteins in neural-derived exosomes of COVID-19. Ann. Neurol. 91, 772\u2013781 (2022).","journal-title":"Ann. Neurol."},{"key":"1601_CR45","doi-asserted-by":"publisher","unstructured":"Craddock, V. et al. Persistent circulation of soluble and extracellular vesicle-linked Spike protein in individuals with postacute sequelae of COVID-19. J. Med. Virol. https:\/\/doi.org\/10.1002\/JMV.28568 (2023).","DOI":"10.1002\/JMV.28568"},{"key":"1601_CR46","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41586-020-03146-y","volume":"590","author":"C Adaken","year":"2021","unstructured":"Adaken, C. et al. Ebola virus antibody decay\u2013stimulation in a high proportion of survivors. Nature 590, 468\u2013472 (2021).","journal-title":"Nature"},{"key":"1601_CR47","doi-asserted-by":"crossref","first-page":"11474","DOI":"10.1038\/s41598-017-10965-z","volume":"7","author":"AN Nelson","year":"2017","unstructured":"Nelson, A. N. et al. Evolution of T cell responses during measles virus infection and RNA clearance. Sci. Rep. 7, 11474 (2017).","journal-title":"Sci. Rep."},{"key":"1601_CR48","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41590-022-01274-3","volume":"23","author":"RS Herati","year":"2022","unstructured":"Herati, R. S. et al. PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine. Nat. Immunol. 23, 1183\u20131192 (2022).","journal-title":"Nat. Immunol."},{"key":"1601_CR49","doi-asserted-by":"publisher","unstructured":"Herati, R. S. et al. Vaccine-induced ICOS+CD38+ circulating Tfh are sensitive biosensors of age-related changes in inflammatory pathways. Cell Rep. Med. https:\/\/doi.org\/10.1016\/J.XCRM.2021.100262 (2021).","DOI":"10.1016\/J.XCRM.2021.100262"},{"key":"1601_CR50","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1074-7613(00)80483-5","volume":"4","author":"Y Sykulev","year":"1996","unstructured":"Sykulev, Y., Joo, M., Vturina, I., Tsomides, T. J. & Eisen, H. N. Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4, 565\u2013571 (1996).","journal-title":"Immunity"},{"key":"1601_CR51","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","volume":"77","author":"EJ Wherry","year":"2003","unstructured":"Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R. & Ahmed, R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77, 4911\u20134927 (2003).","journal-title":"J. Virol."},{"key":"1601_CR52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nm0402-379","volume":"8","author":"V Appay","year":"2002","unstructured":"Appay, V. et al. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8, 379\u2013385 (2002).","journal-title":"Nat. Med."},{"key":"1601_CR53","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ni1058","volume":"5","author":"MA Purbhoo","year":"2004","unstructured":"Purbhoo, M. A., Irvine, D. J., Huppa, J. B. & Davis, M. M. T cell killing does not require the formation of a stable mature immunological synapse. Nat. Immunol. 5, 524\u2013530 (2004).","journal-title":"Nat. Immunol."},{"key":"1601_CR54","doi-asserted-by":"publisher","unstructured":"Vibholm, L. K. et al. SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses. EBioMedicine https:\/\/doi.org\/10.1016\/j.ebiom.2021.103230 (2021).","DOI":"10.1016\/j.ebiom.2021.103230"},{"key":"1601_CR55","doi-asserted-by":"publisher","unstructured":"Peluso, M. J. et al. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. https:\/\/doi.org\/10.1016\/J.CELREP.2021.109518 (2021).","DOI":"10.1016\/J.CELREP.2021.109518"},{"key":"1601_CR56","doi-asserted-by":"crossref","first-page":"e1010359","DOI":"10.1371\/journal.ppat.1010359","volume":"18","author":"KM Littlefield","year":"2022","unstructured":"Littlefield, K. M. et al. SARS-CoV-2-specific T cells associate with inflammation and reduced lung function in pulmonary post-acute sequalae of SARS-CoV-2. PLoS Pathog. 18, e1010359 (2022).","journal-title":"PLoS Pathog."},{"key":"1601_CR57","doi-asserted-by":"publisher","unstructured":"Visvabharathy, L. et al. T cell responses to SARS-CoV-2 in people with and without neurologic symptoms of long COVID. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2021.08.08.21261763 (2022).","DOI":"10.1101\/2021.08.08.21261763"},{"key":"1601_CR58","doi-asserted-by":"publisher","unstructured":"Yin, K. et al. Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.02.09.527892 (2023).","DOI":"10.1101\/2023.02.09.527892"},{"key":"1601_CR59","doi-asserted-by":"publisher","unstructured":"Klein, J. et al. Distinguishing features of Long COVID identified through immune profiling. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2022.08.09.22278592 (2022).","DOI":"10.1101\/2022.08.09.22278592"},{"key":"1601_CR60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-37368-1","volume":"14","author":"A Santa Cruz","year":"2023","unstructured":"Santa Cruz, A. et al. Post-acute sequelae of COVID-19 is characterized by diminished peripheral CD8+ \u03b27 integrin+ T cells and anti-SARS-CoV-2 IgA response. Nat. Commun. 14, 1772 (2023).","journal-title":"Nat. Commun."},{"key":"1601_CR61","doi-asserted-by":"crossref","first-page":"11490\u201311501","DOI":"10.1128\/JVI.05379-11","volume":"85","author":"TU Metcalf","year":"2011","unstructured":"Metcalf, T. U. & Griffin, D. E. Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system. J. Virol. 85, 11490\u201311501 (2011).","journal-title":"J. Virol."},{"key":"1601_CR62","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/JVI.01769-12","volume":"87","author":"TU Metcalf","year":"2013","unstructured":"Metcalf, T. U., Baxter, V. K., Nilaratanakul, V. & Griffin, D. E. Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis. J. Virol. 87, 2420\u20132429 (2013).","journal-title":"J. Virol."},{"key":"1601_CR63","doi-asserted-by":"publisher","unstructured":"Nelson, A. N. et al. Association of persistent wild-type measles virus RNA with long-term humoral immunity in rhesus macaques. JCI Insight https:\/\/doi.org\/10.1172\/JCI.INSIGHT.134992 (2020).","DOI":"10.1172\/JCI.INSIGHT.134992"},{"key":"1601_CR64","doi-asserted-by":"crossref","first-page":"109961","DOI":"10.1016\/j.celrep.2021.109961","volume":"37","author":"WT Yewdell","year":"2021","unstructured":"Yewdell, W. T. et al. Temporal dynamics of persistent germinal centers and memory B cell differentiation following respiratory virus infection. Cell Rep. 37, 109961 (2021).","journal-title":"Cell Rep."},{"key":"1601_CR65","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1084\/jem.20092017","volume":"207","author":"TS Kim","year":"2010","unstructured":"Kim, T. S., Hufford, M. M., Sun, J., Fu, Y. X. & Braciale, T. J. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J. Exp. Med. 207, 1161\u20131172 (2010).","journal-title":"J. Exp. Med."},{"key":"1601_CR66","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cell.2022.11.031","volume":"186","author":"RVH de Carvalho","year":"2023","unstructured":"de Carvalho, R. V. H. et al. Clonal replacement sustains long-lived germinal centers primed by respiratory viruses. Cell 186, 131\u2013146 (2023).","journal-title":"Cell"},{"key":"1601_CR67","doi-asserted-by":"publisher","unstructured":"Rashid, F. et al. Roles and functions of SARS-CoV-2 proteins in host immune evasion. Front. Immunol. https:\/\/doi.org\/10.3389\/FIMMU.2022.940756 (2022).","DOI":"10.3389\/FIMMU.2022.940756"},{"key":"1601_CR68","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41586-022-05282-z","volume":"610","author":"J Kee","year":"2022","unstructured":"Kee, J. et al. SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. Nature 610, 381\u2013388 (2022).","journal-title":"Nature"},{"key":"1601_CR69","doi-asserted-by":"publisher","unstructured":"Pretorius, E. et al. Persistent clotting protein pathology in Long COVID\/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. https:\/\/doi.org\/10.1186\/s12933-021-01359-7 (2021).","DOI":"10.1186\/s12933-021-01359-7"},{"key":"1601_CR70","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20210611","author":"LM Grobbelaar","year":"2021","unstructured":"Grobbelaar, L. M. et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci. Rep. https:\/\/doi.org\/10.1042\/BSR20210611 (2021).","journal-title":"Biosci. Rep."},{"key":"1601_CR71","doi-asserted-by":"publisher","unstructured":"Ryu, J. K. et al. SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2021.10.12.464152 (2021).","DOI":"10.1101\/2021.10.12.464152"},{"key":"1601_CR72","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13045-022-01329-w","volume":"15","author":"M De Michele","year":"2022","unstructured":"De Michele, M. et al. Evidence of SARS-CoV-2 spike protein on retrieved thrombi from COVID-19 patients. J. Hematol. Oncol. 15, 108 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"1601_CR73","doi-asserted-by":"publisher","unstructured":"Boribong, B. P. et al. Neutrophil profiles of pediatric COVID-19 and multisystem inflammatory syndrome in children. Cell Rep. Med. https:\/\/doi.org\/10.1016\/J.XCRM.2022.100848 (2022).","DOI":"10.1016\/J.XCRM.2022.100848"},{"key":"1601_CR74","doi-asserted-by":"publisher","unstructured":"Cervia, C. et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. https:\/\/doi.org\/10.1038\/S41467-021-27797-1 (2022).","DOI":"10.1038\/S41467-021-27797-1"},{"key":"1601_CR75","doi-asserted-by":"crossref","first-page":"718\u2013724","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"1601_CR76","doi-asserted-by":"publisher","unstructured":"Gold, J. E., Okyay, R. A., Licht, W. E. & Hurley, D. J. Investigation of long COVID prevalence and its relationship to Epstein\u2013Barr virus reactivation. Pathogens https:\/\/doi.org\/10.3390\/PATHOGENS10060763 (2021).","DOI":"10.3390\/PATHOGENS10060763"},{"key":"1601_CR77","doi-asserted-by":"publisher","DOI":"10.1172\/JCI163669","author":"MJ Peluso","year":"2022","unstructured":"Peluso, M. J. et al. Impact of pre-existing chronic viral infection and reactivation on the development of long COVID. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI163669 (2022).","journal-title":"J. Clin. Invest."},{"key":"1601_CR78","doi-asserted-by":"publisher","unstructured":"Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell https:\/\/doi.org\/10.1016\/j.cell.2022.01.014 (2022).","DOI":"10.1016\/j.cell.2022.01.014"},{"key":"1601_CR79","doi-asserted-by":"publisher","unstructured":"Gu, L. et al. Dynamic changes in the microbiome and mucosal immune microenvironment of the lower respiratory tract by influenza virus infection. Front Microbiol. https:\/\/doi.org\/10.3389\/FMICB.2019.02491 (2019).","DOI":"10.3389\/FMICB.2019.02491"},{"key":"1601_CR80","doi-asserted-by":"publisher","unstructured":"Kaul, D. et al. Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection. Nat Commun. https:\/\/doi.org\/10.1038\/s41467-020-16429-9 (2020).","DOI":"10.1038\/s41467-020-16429-9"},{"key":"1601_CR81","doi-asserted-by":"crossref","unstructured":"Eastment, M. C. & McClelland, R. S. Vaginal microbiota and susceptibility to HIV. AIDS 32, 687\u2013698 (2018).","DOI":"10.1097\/QAD.0000000000001768"},{"key":"1601_CR82","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","volume":"71","author":"Q Liu","year":"2022","unstructured":"Liu, Q. et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut 71, 544\u2013552 (2022).","journal-title":"Gut"},{"key":"1601_CR83","doi-asserted-by":"publisher","unstructured":"Giron, L. B. et al. Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-\u03baB signaling. JCI Insight https:\/\/doi.org\/10.1172\/JCI.INSIGHT.160989 (2022).","DOI":"10.1172\/JCI.INSIGHT.160989"},{"key":"1601_CR84","doi-asserted-by":"publisher","unstructured":"Yonker, L. M. et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI149633 (2021).","DOI":"10.1172\/JCI149633"},{"key":"1601_CR85","doi-asserted-by":"publisher","unstructured":"Wang, W., Uzzau, S., Goldblum, S. E. & Fasano, A. Human zonulin, a potential modulator of intestinal tight junctions. J. Cell Sci. https:\/\/doi.org\/10.1242\/jcs.113.24.4435 (2000).","DOI":"10.1242\/jcs.113.24.4435"},{"key":"1601_CR86","doi-asserted-by":"publisher","unstructured":"Fasano, A. et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(00)02169-3 (2000).","DOI":"10.1016\/S0140-6736(00)02169-3"},{"key":"1601_CR87","doi-asserted-by":"crossref","first-page":"e0274289","DOI":"10.1371\/journal.pone.0274289","volume":"17","author":"A Malik","year":"2022","unstructured":"Malik, A. et al. Distorted TCR repertoires define multisystem inflammatory syndrome in children. PLoS ONE 17, e0274289 (2022).","journal-title":"PLoS ONE"},{"key":"1601_CR88","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41577-020-00458-y","volume":"20","author":"J Kreye","year":"2020","unstructured":"Kreye, J., Reincke, S. M. & Pr\u00fcss, H. Do cross-reactive antibodies cause neuropathology in COVID-19. Nat. Rev. Immunol. 20, 645\u2013646 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"1601_CR89","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz, T. V. et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 603, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"1601_CR90","doi-asserted-by":"crossref","first-page":"84\u201398","DOI":"10.1242\/jeb.073411","volume":"216","author":"RH McCusker","year":"2013","unstructured":"McCusker, R. H. & Kelley, K. W. Immune\u2013neural connections: how the immune system\u2019s response to infectious agents influences behavior. J. Exp. Biol. 216, 84\u201398 (2013).","journal-title":"J. Exp. Biol."},{"key":"1601_CR91","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbi.2004.09.002","volume":"19","author":"LE Goehler","year":"2005","unstructured":"Goehler, L. E. et al. Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav. Immun. 19, 334\u2013344 (2005).","journal-title":"Brain Behav. Immun."},{"key":"1601_CR92","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.mehy.2013.05.034","volume":"81","author":"MB VanElzakker","year":"2013","unstructured":"VanElzakker, M. B. Chronic fatigue syndrome from vagus nerve infection: a psychoneuroimmunological hypothesis. Med. Hypotheses 81, 414\u2013423 (2013).","journal-title":"Med. Hypotheses"},{"key":"1601_CR93","doi-asserted-by":"crossref","unstructured":"Woo, M. S. et al. Vagus nerve inflammation contributes to dysautonomia in COVID-19. Acta Neuropathol. 146, 387\u2013394 (2023).","DOI":"10.1007\/s00401-023-02612-x"},{"key":"1601_CR94","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1474-4422(20)30308-2","volume":"19","author":"J Matschke","year":"2020","unstructured":"Matschke, J. et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series. Lancet Neurol. 19, 919\u2013929 (2020).","journal-title":"Lancet Neurol."},{"key":"1601_CR95","doi-asserted-by":"publisher","unstructured":"Song, E. et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. https:\/\/doi.org\/10.1084\/JEM.20202135 (2021).","DOI":"10.1084\/JEM.20202135"},{"key":"1601_CR96","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3233\/JAD-220717","volume":"89","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Association of COVID-19 with new-onset Alzheimer\u2019s disease. J. Alzheimers Dis. 89, 411\u2013414 (2022).","journal-title":"J. Alzheimers Dis."},{"key":"1601_CR97","doi-asserted-by":"publisher","unstructured":"Rhodes, C. H., Priemer, D. S., Karlovich, E., Perl, D. P. & Goldman, J. \u03b2-amyloid deposits in young COVID patients. SSRN Electronic Journal https:\/\/doi.org\/10.2139\/SSRN.4003213 (2022).","DOI":"10.2139\/SSRN.4003213"},{"key":"1601_CR98","doi-asserted-by":"publisher","unstructured":"Soscia, S. J. et al. The Alzheimer\u2019s disease-associated amyloid \u03b2-protein is an antimicrobial peptide. PLoS ONE https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0009505 (2010).","DOI":"10.1371\/JOURNAL.PONE.0009505"},{"key":"1601_CR99","doi-asserted-by":"crossref","first-page":"56\u201363","DOI":"10.1016\/j.neuron.2018.06.030","volume":"99","author":"WA Eimer","year":"2018","unstructured":"Eimer, W. A. et al. Alzheimer\u2019s disease-associated \u03b2-amyloid is rapidly seeded by herpesviridae to protect against brain infection. Neuron 99, 56\u201363 (2018).","journal-title":"Neuron"},{"key":"1601_CR100","first-page":"340ra72","volume":"8","author":"DKV Kumar","year":"2016","unstructured":"Kumar, D. K. V. et al. Amyloid-\u03b2 peptide protects against microbial infection in mouse and worm models of Alzheimer\u2019s disease. Sci. Transl. Med. 8, 340ra72 (2016).","journal-title":"Sci. Transl. Med."},{"key":"1601_CR101","doi-asserted-by":"publisher","unstructured":"Aung, A. et al. Low protease activity in B cell follicles promotes retention of intact antigens after immunization. Science https:\/\/doi.org\/10.1126\/SCIENCE.ABN8934\/SUPPL_FILE\/SCIENCE.ABN8934_MDAR_REPRODUCIBILITY_CHECKLIST.PDF (2023).","DOI":"10.1126\/SCIENCE.ABN8934\/SUPPL_FILE\/SCIENCE.ABN8934_MDAR_REPRODUCIBILITY_CHECKLIST.PDF"},{"key":"1601_CR102","doi-asserted-by":"crossref","first-page":"e3001687","DOI":"10.1371\/journal.pbio.3001687","volume":"20","author":"DE Griffin","year":"2022","unstructured":"Griffin, D. E. Why does viral RNA sometimes persist after recovery from acute infections? PLoS Biol. 20, e3001687 (2022).","journal-title":"PLoS Biol."},{"key":"1601_CR103","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1098612X19886671","volume":"22","author":"L Emmler","year":"2020","unstructured":"Emmler, L. et al. Feline coronavirus with and without spike gene mutations detected by real-time RT\u2013PCRs in cats with feline infectious peritonitis. J. Feline Med. Surg. 22, 791\u2013799 (2020).","journal-title":"J. Feline Med. Surg."},{"key":"1601_CR104","doi-asserted-by":"crossref","unstructured":"Arshad, N. et al. SARS-CoV-2 accessory proteins ORF7a and ORF3a use distinct mechanisms to down-regulate MHC-I surface expression. Proc. Natl Acad. Sci. 120, e2208525120120 (2023).","DOI":"10.1073\/pnas.2208525120"},{"key":"1601_CR105","doi-asserted-by":"publisher","unstructured":"Moriyama, M., Lucas, C., Monteiro, V. S., Yale SARS-CoV-2 Genomic Surveillance Initiative & Iwasaki, A. SARS-CoV-2 Omicron subvariants evolved to promote further escape from MHC-I recognition. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2022.05.04.490614 (2022).","DOI":"10.1101\/2022.05.04.490614"},{"key":"1601_CR106","doi-asserted-by":"publisher","unstructured":"Peluso, M. J. et al. Effect of oral nirmatrelvir on Long COVID symptoms: a case series. https:\/\/doi.org\/10.21203\/RS.3.RS-1617822\/V2 (2022).","DOI":"10.21203\/RS.3.RS-1617822\/V2"},{"key":"1601_CR107","doi-asserted-by":"publisher","unstructured":"Geng, L. N., Bonilla, H. F., Shafer, R. W., Miglis, M. G., Yang, P. C. Case report of breakthrough long COVID and the use of nirmatrelvir-ritonavir. Preprint at Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-1443341\/v1 (2022).","DOI":"10.21203\/rs.3.rs-1443341\/v1"},{"key":"1601_CR108","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-04482-x","volume":"604","author":"DC Schultz","year":"2022","unstructured":"Schultz, D. C. et al. Pyrimidine inhibitors synergize with nucleoside analogues to block SARS-CoV-2. Nature 604, 134\u2013140 (2022).","journal-title":"Nature"},{"key":"1601_CR109","doi-asserted-by":"publisher","unstructured":"Xie, Y., Choi, T. & Al-Aly Z. Nirmatrelvir and the risk of post-acute sequelae of COVID-19. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2022.11.03.22281783 (2022).","DOI":"10.1101\/2022.11.03.22281783"},{"key":"1601_CR110","doi-asserted-by":"crossref","first-page":"e0641","DOI":"10.1097\/CCE.0000000000000641","volume":"4","author":"LM Yonker","year":"2022","unstructured":"Yonker, L. M. et al. Zonulin antagonist, Larazotide (AT1001), as an adjuvant treatment for multisystem inflammatory syndrome in children: a case series. Crit. Care Explor. 4, e0641 (2022).","journal-title":"Crit. Care Explor."},{"key":"1601_CR111","doi-asserted-by":"publisher","unstructured":"Proal, A. & Marshall, T. Myalgic encephalomyelitis\/chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity. Front. Pediatr. https:\/\/doi.org\/10.3389\/fped.2018.00373 (2018).","DOI":"10.3389\/fped.2018.00373"},{"key":"1601_CR112","doi-asserted-by":"crossref","unstructured":"Bjornevik, K. et al. Longitudinal analysis reveals high prevalence of Epstein\u2013Barr virus associated with multiple sclerosis. Science 375, 296\u2013301 (2022).","DOI":"10.1126\/science.abj8222"},{"key":"1601_CR113","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","volume":"50","author":"JB Harley","year":"2018","unstructured":"Harley, J. B. et al. Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity. Nat. Genet. 50, 699\u2013707 (2018).","journal-title":"Nat. Genet."},{"key":"1601_CR114","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/gutjnl-2021-324280","volume":"71","author":"CCL Cheung","year":"2022","unstructured":"Cheung, C. C. L. et al. Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19. Gut 71, 226\u2013229 (2022).","journal-title":"Gut"},{"key":"1601_CR115","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.medj.2022.04.001","volume":"3","author":"A Natarajan","year":"2022","unstructured":"Natarajan, A. et al. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 3, 371\u2013387 (2022).","journal-title":"Med."},{"key":"1601_CR116","doi-asserted-by":"publisher","unstructured":"Jin, J. C. et al. SARS-CoV-2 detected in neonatal stool remote from maternal COVID-19 during pregnancy. Pediatr. Res. https:\/\/doi.org\/10.1038\/s41390-022-02266-7 (2022).","DOI":"10.1038\/s41390-022-02266-7"},{"key":"1601_CR117","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12879-022-07153-4","volume":"22","author":"F Tejerina","year":"2022","unstructured":"Tejerina, F. et al. Post-COVID-19 syndrome. SARS-CoV-2 RNA detection in plasma, stool, and urine in patients with persistent symptoms after COVID-19. BMC Infect. Dis. 22, 211 (2022).","journal-title":"BMC Infect. Dis."}],"updated-by":[{"DOI":"10.1038\/s41590-023-01646-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T00:00:00Z","timestamp":1694995200000}}],"container-title":["Nature Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01601-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01601-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01601-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T09:09:42Z","timestamp":1695719382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41590-023-01601-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":117,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1601"],"URL":"https:\/\/doi.org\/10.1038\/s41590-023-01601-2","relation":{},"ISSN":["1529-2908","1529-2916"],"issn-type":[{"value":"1529-2908","type":"print"},{"value":"1529-2916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"30 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41590-023-01646-3","URL":"https:\/\/doi.org\/10.1038\/s41590-023-01646-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.D.P. has received consulting fees from Enanta Pharmaceuticals outside the submitted work. S.A. has received honoraria for lectures and educational events from Gilead, AbbVie, MSD and Biogen, and reports grants from Gilead and AbbVie. E.W.E. has received grant support\/research funding from the US National Institutes of Health and Veterans Administration, is an unfunded investigator with baricitinib on COVID-19 studies funded by Eli Lilly, and has lectured at events related to sedation in the intensive care unit sponsored by Pfizer. M.F. reports a relationship with Mars that includes board membership. L.N.G. reports receiving grants from Pfizer and advisory fees from UnitedHealthcare. D.E.G. is a member of the scientific advisory committees for GSK, Merck and Takeda Pharmaceuticals. T.J.H. consults for Roche and received grant support from Merck. A.I. cofounded and consults for RIGImmune, Xanadu Bio and PanV; consults for Paratus Sciences, InvisiShield Technologies; and is a member of the Board of Directors of Roche Holding. M.J.P. has received consulting fees from Gilead Sciences and AstraZeneca, outside the submitted work. E.P. founded Biocode Technologies and holds a patent for detection of microclots in blood samples. E.J.W. is a member of the Parker Institute for Cancer Immunotherapy, which supports cancer immunology research in the laboratory of E.J.W. E.J.W. is an advisor for Danger Bio, Janssen, New Limit, Marengo, Pluto Immunotherapeutics, Related Sciences, Santa Ana Bio, Synthekine and Surface Oncology. E.J.W. is a founder of and holds stock in Surface Oncology, Danger Bio and Arsenal Biosciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}